1. Home
  2. ZYXI vs DLHC Comparison

ZYXI vs DLHC Comparison

Compare ZYXI & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • DLHC
  • Stock Information
  • Founded
  • ZYXI 1996
  • DLHC 1969
  • Country
  • ZYXI United States
  • DLHC United States
  • Employees
  • ZYXI N/A
  • DLHC N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DLHC Business Services
  • Sector
  • ZYXI Health Care
  • DLHC Consumer Discretionary
  • Exchange
  • ZYXI Nasdaq
  • DLHC Nasdaq
  • Market Cap
  • ZYXI 66.5M
  • DLHC 75.1M
  • IPO Year
  • ZYXI N/A
  • DLHC N/A
  • Fundamental
  • Price
  • ZYXI $2.18
  • DLHC $3.52
  • Analyst Decision
  • ZYXI Buy
  • DLHC
  • Analyst Count
  • ZYXI 3
  • DLHC 0
  • Target Price
  • ZYXI $10.25
  • DLHC N/A
  • AVG Volume (30 Days)
  • ZYXI 262.3K
  • DLHC 98.4K
  • Earning Date
  • ZYXI 04-29-2025
  • DLHC 04-30-2025
  • Dividend Yield
  • ZYXI N/A
  • DLHC N/A
  • EPS Growth
  • ZYXI N/A
  • DLHC 205.25
  • EPS
  • ZYXI 0.09
  • DLHC 0.44
  • Revenue
  • ZYXI $192,354,000.00
  • DLHC $388,869,000.00
  • Revenue This Year
  • ZYXI N/A
  • DLHC N/A
  • Revenue Next Year
  • ZYXI $23.16
  • DLHC N/A
  • P/E Ratio
  • ZYXI $24.22
  • DLHC $8.12
  • Revenue Growth
  • ZYXI 4.36
  • DLHC N/A
  • 52 Week Low
  • ZYXI $1.93
  • DLHC $2.72
  • 52 Week High
  • ZYXI $12.19
  • DLHC $12.23
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 26.14
  • DLHC 41.40
  • Support Level
  • ZYXI $2.03
  • DLHC $2.72
  • Resistance Level
  • ZYXI $2.24
  • DLHC $3.89
  • Average True Range (ATR)
  • ZYXI 0.18
  • DLHC 0.35
  • MACD
  • ZYXI 0.17
  • DLHC 0.04
  • Stochastic Oscillator
  • ZYXI 38.46
  • DLHC 46.78

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.

Share on Social Networks: